首页 | 本学科首页   官方微博 | 高级检索  
     


A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus‐positive patients with cancer: AIDS Malignancy Consortium trial AMC 061
Authors:Michelle A. Rudek PharmD  PhD  Page C. Moore PhD  Ronald T. Mitsuyasu MD  Bruce J. Dezube MD  David Aboulafia MD  John Gerecitano MD  PhD  Ryan Sullivan MD  Mary E. Cianfrocca DO  David H. Henry MD  Lee Ratner MD  PhD  Missak Haigentz Jr.   MD  Afshin Dowlati MD  Richard F. Little MD  Susan Percy Ivy MD  John F. Deeken MD
Affiliation:1. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland;2. Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas;3. Department of Medicine, Center for Clinical AIDS Research and Education (CARE Center), University of California at Los Angeles, Los Angeles, California;4. Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts;5. Division of Hematology and Oncology, Virginia Mason Medical Center, University of Washington, Seattle, Washington;6. Lymphoma Service, Department of Medicine, Memorial Sloan‐Kettering Cancer Center, New York, New York;7. Massachusetts General Hospital Cancer Center, Boston, Massachusetts;8. Northwestern University, Chicago, Illinois;9. Department of Medicine, Pennsylvania Hospital, Philadelphia, Pennsylvania;10. Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri;11. Division of Oncology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York;12. Department of Medicine, Case Comprehensive Cancer Center, Cleveland, Ohio;13. Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Washington, DC;14. Division of Medical Oncology/Hematology, Inova Comprehensive Cancer and Research Institute, Falls Church, Virginia
Abstract:
Keywords:phase 1  sunitinib  human immunodeficiency virus (HIV)  clinical trial  highly active antiretroviral therapy (HAART)
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号